Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 125

1.

Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.

Porteous MK, Lee JC, Lederer DJ, Palmer SM, Cantu E, Shah RJ, Bellamy SL, Lama VN, Bhorade SM, Crespo MM, McDyer JF, Wille KM, Localio AR, Orens JB, Shah PD, Weinacker AB, Arcasoy S, Wilkes DS, Ware LB, Christie JD, Kawut SM, Diamond JM; Lung Transplant Outcomes Group.

Ann Am Thorac Soc. 2017 Oct;14(10):1514-1522. doi: 10.1513/AnnalsATS.201610-810OC.

PMID:
28719755
2.

An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.

Forcade E, Paz K, Flynn R, Griesenauer B, Amet T, Li W, Liu L, Bakoyannis G, Jiang D, Chu HW, Lobera M, Yang J, Wilkes DS, Du J, Gartlan K, Hill GR, MacDonald KP, Espada EL, Blanco P, Serody JS, Koreth J, Cutler CS, Antin JH, Soiffer RJ, Ritz J, Paczesny S, Blazar BR.

JCI Insight. 2017 Jun 15;2(12). pii: 92111. doi: 10.1172/jci.insight.92111. [Epub ahead of print]

3.

Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Lama VN, Belperio JA, Christie JD, El-Chemaly S, Fishbein MC, Gelman AE, Hancock WW, Keshavjee S, Kreisel D, Laubach VE, Looney MR, McDyer JF, Mohanakumar T, Shilling RA, Panoskaltsis-Mortari A, Wilkes DS, Eu JP, Nicolls MR.

JCI Insight. 2017 May 4;2(9). pii: 93121. doi: 10.1172/jci.insight.93121. [Epub ahead of print] Review.

4.

Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.

Sullivan JA, Jankowska-Gan E, Hegde S, Pestrak MA, Agashe VV, Park AC, Brown ME, Kernien JF, Wilkes DS, Kaufman DB, Greenspan DS, Burlingham WJ.

Am J Transplant. 2017 Apr;17(4):944-956. doi: 10.1111/ajt.14097. Epub 2016 Dec 19.

PMID:
27801552
5.

Hypoxia-Inducible Factor-1α Regulates CD55 in Airway Epithelium.

Pandya PH, Fisher AJ, Mickler EA, Temm CJ, Lipking KP, Gracon A, Rothhaar K, Sandusky GE, Murray M, Pollok K, Renbarger J, Blum JS, Lahm T, Wilkes DS.

Am J Respir Cell Mol Biol. 2016 Dec;55(6):889-898.

6.

Regulation of Collagen V Expression and Epithelial-Mesenchymal Transition by miR-185 and miR-186 during Idiopathic Pulmonary Fibrosis.

Lei GS, Kline HL, Lee CH, Wilkes DS, Zhang C.

Am J Pathol. 2016 Sep;186(9):2310-6. doi: 10.1016/j.ajpath.2016.04.015. Epub 2016 Jul 5.

7.

Human leukocyte antigen-DR13 and DR15 are associated with short-term lung transplant outcomes.

Gracon AS, Liang TW, Rothhaar K, Wu J, Wilkes DS.

J Surg Res. 2016 Jun 1;203(1):82-90. doi: 10.1016/j.jss.2016.03.041. Epub 2016 Mar 26.

PMID:
27338538
8.

National Heart, Lung, and Blood Institute Workshop Summary: Enhancing Opportunities for Training and Retention of a Diverse Biomedical Workforce.

Duncan GA, Lockett A, Villegas LR, Almodovar S, Gomez JL, Flores SC, Wilkes DS, Tigno XT.

Ann Am Thorac Soc. 2016 Apr;13(4):562-7. doi: 10.1513/AnnalsATS.201509-624OT.

9.

Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.

Gu H, Fisher AJ, Mickler EA, Duerson F 3rd, Cummings OW, Peters-Golden M, Twigg HL 3rd, Woodruff TM, Wilkes DS, Vittal R.

FASEB J. 2016 Jun;30(6):2336-50. doi: 10.1096/fj.201500044. Epub 2016 Mar 8.

10.

Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.

Liu X, Yue Z, Yu J, Daguindau E, Kushekhar K, Zhang Q, Ogata Y, Gafken PR, Inamoto Y, Gracon A, Wilkes DS, Hansen JA, Lee SJ, Chen JY, Paczesny S.

Am J Transplant. 2016 Aug;16(8):2342-51. doi: 10.1111/ajt.13750. Epub 2016 Mar 14.

11.

The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.

Diamond JM, Porteous MK, Roberts LJ 2nd, Wickersham N, Rushefski M, Kawut SM, Shah RJ, Cantu E 3rd, Lederer DJ, Chatterjee S, Lama VN, Bhorade S, Crespo M, McDyer J, Wille K, Orens J, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Hage C, Palmer SM, Snyder L, Calfee CS, Ware LB, Christie JD; Lung Transplant Outcomes Group.

J Heart Lung Transplant. 2016 Apr;35(4):500-507. doi: 10.1016/j.healun.2015.12.012. Epub 2016 Jan 7.

12.

Mucosal Administration of Collagen V Ameliorates the Atherosclerotic Plaque Burden by Inducing Interleukin 35-dependent Tolerance.

Park AC, Huang G, Jankowska-Gan E, Massoudi D, Kernien JF, Vignali DA, Sullivan JA, Wilkes DS, Burlingham WJ, Greenspan DS.

J Biol Chem. 2016 Feb 12;291(7):3359-70. doi: 10.1074/jbc.M115.681882. Epub 2015 Dec 31.

13.

Exploring autoimmunity in the pathogenesis of abdominal aortic aneurysms.

Chang TW, Gracon AS, Murphy MP, Wilkes DS.

Am J Physiol Heart Circ Physiol. 2015 Sep;309(5):H719-27. doi: 10.1152/ajpheart.00273.2015. Epub 2015 Jun 26. Review.

PMID:
26116712
14.

Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation.

Shah RJ, Diamond JM, Cantu E, Flesch J, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Roe D, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Demissie E, Sonnet J, Shah A, Kawut SM, Bellamy SL, Localio AR, Christie JD.

Am J Transplant. 2015 Aug;15(8):2188-96. doi: 10.1111/ajt.13262. Epub 2015 Apr 15.

15.

CD4 T Cells but Not Th17 Cells Are Required for Mouse Lung Transplant Obliterative Bronchiolitis.

Wu Q, Gupta PK, Suzuki H, Wagner SR, Zhang C, W Cummings O, Fan L, Kaplan MH, Wilkes DS, Shilling RA.

Am J Transplant. 2015 Jul;15(7):1793-1804. doi: 10.1111/ajt.13215. Epub 2015 Mar 13.

16.

The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction.

Weber DJ, Allette YM, Wilkes DS, White FA.

Antioxid Redox Signal. 2015 Dec 10;23(17):1316-28. doi: 10.1089/ars.2015.6299. Epub 2015 May 14. Review.

17.

Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis.

Wilkes DS, Chew T, Flaherty KR, Frye S, Gibson KF, Kaminski N, Klemsz MJ, Lange W, Noth I, Rothhaar K.

Eur Respir J. 2015 May;45(5):1393-402. doi: 10.1183/09031936.00105314. Epub 2015 Jan 22.

18.

Lung size mismatch and primary graft dysfunction after bilateral lung transplantation.

Eberlein M, Reed RM, Bolukbas S, Diamond JM, Wille KM, Orens JB, Brower RG, Christie JD; Lung Transplant Outcomes Group.

J Heart Lung Transplant. 2015 Feb;34(2):233-40. doi: 10.1016/j.healun.2014.09.030. Epub 2014 Sep 28.

19.

Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation.

Cantu E, Shah RJ, Lin W, Daye ZJ, Diamond JM, Suzuki Y, Ellis JH, Borders CF, Andah GA, Beduhn B, Meyer NJ, Ruschefski M, Aplenc R, Feng R, Christie JD; Lung Transplant Outcomes Group Investigators.

J Thorac Cardiovasc Surg. 2015 Feb;149(2):596-602. doi: 10.1016/j.jtcvs.2014.09.077. Epub 2014 Sep 28.

20.

An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.

Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, Brozek J, Glanville AR; ISHLT/ATS/ERS BOS Task Force Committee; ISHLT/ATS/ERS BOS Task Force Committee.

Eur Respir J. 2014 Dec;44(6):1479-503. doi: 10.1183/09031936.00107514. Epub 2014 Oct 30.

Supplemental Content

Loading ...
Support Center